Presented for research literature review only Kameyama M et al
If you are having trouble with your mobile device or do not own a smartphone, dont worry you can use the website on a desktop computer or laptop to sign up just as easily
En personas con sobrepeso y obesidad, la administracin de este anlogo del GLP-1 que se administra en forma inyectable mediante una lapicera prellenada mimetiza el mecanismo natural que se produce en el cuerpo humano, promoviendo ms saciedad y control del apetito, lo que resulta en una menor ingesta de alimentos y la consecuente prdida de peso, explic la doctora Miriam Tonietti, ex presidente de la Sociedad Argentina de Nutricin
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis KEY MARKET PLAYERS Novo Nordisk A/S (Denmark) Eli Lilly and Company (US) Sanofi (France) Hansoh Pharmaceutical Group Co., Ltd
Those were not head-to-head obesity trials, so they are useful for direction, not as a guarantee for any one person
Optional coaching is also available